Status:
COMPLETED
Augmented CBGT for Perinatal Anxiety During a Global Pandemic (COVID-19)
Lead Sponsor:
St. Joseph's Healthcare Hamilton
Conditions:
Perinatal Anxiety
Covid19
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
This study will evaluate the effectiveness of an augmented version of our current evidence-based Cognitive Behavioural Group Therapy (CBGT) for perinatal anxiety protocol with cognitive and behavioura...
Eligibility Criteria
Inclusion
- Females, aged 18-45 years
- Pregnant or up to six months postpartum
- Primary diagnosis of an anxiety disorder, as per the MINI for DSM-5, with or without comorbid depression
- No concurrent psychological treatment
- Not taking psychoactive medication or medication is stable in dose and type for at least 8 weeks prior to the study (as per Canadian Psychiatric Guidelines) and throughout study duration (participants will not be excluded from treatment if medication/dose changes during the study duration, however, they must notify the study team immediately)
- Fluent in English in order to understand the consent and group material
Exclusion
- Severe depression/suicidality
- Primary diagnosis other than an anxiety disorder
- Psychotic or current substance/alcohol use disorder
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT04495803
Start Date
September 1 2020
End Date
September 1 2021
Last Update
May 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada, L8P 3R2